Trial site
The Angeles Clinic and Research Institute
- 14running trials
- 11closed trials
The trials here
What the 25 trials at this site are about, from their registry records.
- Conditions
- Melanoma17 trials
- Colorectal cancer7 trials
- Lung cancer6 trials
- Childhood cancers5 trials
- Head and neck cancer5 trials
- Gastric and oesophageal cancer4 trials
- Endometrial cancer3 trials
- Pancreatic cancer3 trials
- Cervical cancer2 trials
- Liver and biliary tract cancer2 trials
- Ovarian cancer2 trials
- Bladder cancer1 trial
- and 5 more
- Phase
- Phase 17 trials
- Phase 27 trials
- Phase 1/26 trials
- Phase 33 trials
- Phase 2/32 trials
- Status
- Recruiting7 trials
- Completed6 trials
- Active, not recruiting5 trials
- Terminated5 trials
- Not yet recruiting2 trials
- Lead sponsor
- Astellas Pharma Global Development, Inc.3 trials
- Incyte Corporation3 trials
- Iovance Biotherapeutics, Inc.2 trials
- Novartis Pharmaceuticals2 trials
- Replimune, Inc.2 trials
- and 12 more
Running trials
Recruiting
Recruiting
Recruiting
Study of Cemiplimab Plus Ziv-Aflibercept for Subjects With Metastatic Uveal Melanoma
Recruiting
Recruiting
A Study of MGC026 in Participants With Advanced Solid Tumors
Recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Zolbetuximab (IMAB362) in Adults With Gastric Cancer
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Melanoma7 recruiting
- Lung cancer4 recruiting
- Childhood cancers3 recruiting
- Colorectal cancer3 recruiting
- Endometrial cancer2 recruiting
- Head and neck cancer2 recruiting
- Bladder cancer1 recruiting
- Cervical cancer1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Kidney cancer1 recruiting
- Liver and biliary tract cancer1 recruiting
- Ovarian cancer1 recruiting
- Pancreatic cancer1 recruiting
- Prostate cancer1 recruiting
- Sarcoma1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Terminated
Completed
Terminated
Completed
Terminated
Terminated
Terminated
Completed
Completed
Completed
Safety and Efficacy of IMCgp100 Versus Investigator Choice in Advanced Uveal Melanoma
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026